CCM2 抗体 (AA 1-444)
Quick Overview for CCM2 抗体 (AA 1-444) (ABIN2592407)
抗原
See all CCM2 抗体适用
宿主
克隆类型
标记
应用范围
- 
    - 
                                            抗原表位
- AA 1-444
- 
                                            特异性
- Human CCM2 / Malcavernin
- 
                                            纯化方法
- Affinity purified
- 
                                            免疫原
- 
                        Full length human CCM2, aa1-444 (NP_113631.1).
 Type of Immunogen: Recombinant protein
- 
                                            亚型
- IgG
 
- 
                                            
- 
    
- 
    - 
                                            应用备注
- Optimal working dilution should be determined by the investigator.
- 
                                            说明
- 
                        Target Species of Antibody: Human 
- 
                                            限制
- 仅限研究用
 
- 
                                            
- 
    - 
                                            状态
- Liquid
- 
                                            浓度
- Lot specific
- 
                                            缓冲液
- PBS, pH 7.2.
- 
                                            注意事项
- Aliquot to avoid repeated freezing and thawing.
- 
                                            储存条件
- 4 °C,-20 °C
- 
                                            储存方法
- May be stored at 4°C for short-term only. Aliquot to avoid freeze-thaw cycles. Store at -20°C. Aliquots are stable for at least 1 year.
 
- 
                                            
- 
    - CCM2 (Cerebral Cavernous Malformation 2 (CCM2))
- 
                                            别名
- CCM2 / Malcavernin
- 
                                            背景
- 
                        Name/Gene ID: CCM2
 Synonyms: CCM2, C7orf22, Malcavernin, PP10187
- 
                                            基因ID
- 83605
- 
                                            NCBI登录号
- NP_113631
- 
                                            途径
- Cell-Cell Junction Organization
 抗原
- 
                    
 
                                     
                                     
                                    